$1.90 +0.03 (%) Antares Pharma Inc - NASDAQ

Sep. 30, 2014 | 01:49 PM

Partner Headlines

  1. Antares Pharma Announces Additional Patent Coverage for OTREXUP

    Benzinga | Apr. 16, 2014 | 07:21AM EST
  2. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 11, 2014 | 10:17AM EST
  3. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  4. Antares Pharma Announces Availability of OTREXUP Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis in Children

    Benzinga | Jan. 15, 2014 | 07:09AM EST
  5. Antares Pharma Awarded Additional U.S. Patent Protection for OTREXUP™

    Benzinga | Nov. 26, 2013 | 07:05AM EST
  6. Antares Pharma Announces Issuance of Patent for VIBEX Device Platform

    Benzinga | Oct. 25, 2013 | 07:03AM EST
  7. Mid-Afternoon Market Update: Market Holds Awaiting Public Address From Congressional Leaders

    Benzinga | Oct. 14, 2013 | 15:50PM EST
  8. Mid-Day Market Update: US Stocks Pare Losses; Expedia Shares Drop Following Downgrade

    Benzinga | Oct. 14, 2013 | 13:20PM EST
  9. Mid-Morning Market Update: Markets Open Lower; Facebook Acquires Onavo

    Benzinga | Oct. 14, 2013 | 10:53AM EST
  10. Antares Pharma Says FDA Approves OTREXUP Injection for Adults with RA

    Benzinga | Oct. 14, 2013 | 09:25AM EST
  11. Market Wrap For Tuesday, October 1: Government Down, Markets Up

    Benzinga | Oct. 1, 2013 | 16:36PM EST
  12. Mid-Afternoon Market Update: Markets Remain Up As Government Shutdown Continues

    Benzinga | Oct. 1, 2013 | 15:17PM EST
  13. Antares Pharma, Inc. (ATRS) President and CEO Paul K Wotton sells 25,000 Shares

    GuruFocus | Jan. 10, 2013 | 11:05AM EST
  14. Antares Pharma, Inc. (ATRS) Executive Vice President & CFO Robert F Apple sells 25,000 Shares

    GuruFocus | Jan. 10, 2013 | 11:05AM EST
  15. UPDATE: Jefferies & Company Initiates Coverage on Antares Pharma with Buy Rating, $5 PT

    Benzinga | Dec. 19, 2012 | 04:33AM EST
  16. Antares Pharma, Inc. (ATRS) President and CEO Paul K Wotton sells 25,000 Shares

    GuruFocus | Dec. 6, 2012 | 11:08AM EST
  17. Antares Pharma, Inc. (ATRS) Executive Vice President & CFO Robert F Apple sells 25,000 Shares

    GuruFocus | Dec. 6, 2012 | 11:08AM EST
  18. Morning Market Losers

    Benzinga | Oct. 3, 2012 | 03:53AM EST
  19. Antares Pharma Announces Successful Results from VIBEX MTX Trial

    Benzinga | Sep. 25, 2012 | 01:09AM EST
  20. Singles Only: 3 Winning Cheap Stocks No One Cares About

    SchaeffersResearch | Sep. 19, 2012 | 13:32PM EST
  21. Priceline.com, Antares Pharma Among Stocks Gapping Down Wednesday

    FoxBusiness | Aug. 8, 2012 | 04:31AM EST
  22. Antares Pharma (ATRS) Gains 18.4% in Heavy Volume

    MarketIntelligenceCenter | Jul. 9, 2012 | 13:17PM EST
  23. Questcor Pharmaceuticals, Antares Pharma Included in Stocks Up on High Volume Monday

    FoxBusiness | Jul. 9, 2012 | 06:33AM EST
  24. Netflix, Patriot Coal Corporation Included in Stocks Up on High Volume Friday

    FoxBusiness | Jul. 6, 2012 | 06:32AM EST
  25. Synacor, American Capital Mortgage Investment Crp, Other Stocks Hit 52-Week Highs Friday

    FoxBusiness | Jul. 6, 2012 | 06:32AM EST
Trading Center